Ledgewood Wealth Advisors’s Apyx Medical APYX Stock Holding History

Ledgewood Wealth Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$35K	–	74
2025 Q4	$35K	Hold	10,000	–	–	0.02%	70
2025 Q3	$21.4K	Hold	10,000	–	–	0.01%	74
2025 Q2	$22.5K	Hold	10,000	–	–	0.01%	70
2025 Q1	$13.7K	Sell	10,000 -1,493	-13%	-$2.06K	0.01%	70
2024 Q4	$18.2K	Sell	11,493 -20,000	-64%	-$28K	0.01%	69
2024 Q3	$39.1K	Sell	31,493 -179,787	-85%	-$227K	0.03%	72
2024 Q2	$283K	Sell	211,280 -61,475	-23%	-$90.7K	0.24%	48
2024 Q1	$371K	Sell	272,755 -55,625	-17%	-$118K	0.34%	41
2023 Q4	$860K	Buy	+328,380	New	+$795K	0.79%	23

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Ledgewood Wealth Advisors's APYX Position: Q1 2026 in Review

Ledgewood Wealth Advisors sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 10,000 shares — an estimated $35K sold.

Ledgewood Wealth Advisors first reported a position in APYX in Q4 2023 and held it in 9 quarters. The position peaked at $860K in Q4 2023. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Ledgewood Wealth Advisors reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
Ledgewood Wealth Advisors sold 10,000 Apyx Medical shares in Q1 2026, an estimated $35K.
Ledgewood Wealth Advisors first reported a position in Apyx Medical in Q4 2023 and held it in 9 quarters.
Ledgewood Wealth Advisors's Apyx Medical position peaked at $860K in Q4 2023.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Ledgewood Wealth Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.